Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immunochemotherapy, LOXO-305, Lisocabtagene Maraleucel
Comments 0
Login to view comments.
Click here to Login